MedPath

euromodulation in patients undergoing hemodialysis

Not Applicable
Conditions
Chronic Pain
D007676
Registration Number
RBR-46vhrkj
Lead Sponsor
niversidade Federal do Rio Grande do Norte
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age between 18 and 75 years; previous medical evaluation with clinical diagnosis of depression, anxiety, chronic pain and pressure lability and being on hemodialysis treatment

Exclusion Criteria

Evidence of any cognitive deficit (senile dementia, Alzheimer's); presence of physical and / or organic difficulties; individuals with severe cardiovascular risk or hemodynamically unstable; history of seizures or epileptic disease; pregnancy; metallic implants in the head or neck and cardiac pacemaker.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Moderate pain improvement verified by a 30% decrease in the visual analog pain scale in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).
Secondary Outcome Measures
NameTimeMethod
Secondary 1: Depression improvement accornding to moderate (50% of improvement) decrease scores of the Beck depression inventory in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).;Secondary 2: Improvement of 30% or more in anxiety symptom verified by the reduction of the Hamilton Anxiety Questionnaire in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).;Secondary 3: Clinically functionality improvement verified through decrease of more than 5 points the Kidney Disease Quality of Life questionnaire in patients undergoing hemodialysis with transcranial direct current stimulation (tDCS).
© Copyright 2025. All Rights Reserved by MedPath